麻豆传媒

Worse Blood Cancer Outcomes in Hispanics

Diagnosis at earlier age, worse survival, especially for those on U.S.-Mexico border

Jun 24, 2020

Combination Ups Survival in Older AML Patients

Frontline venetoclax plus azacitidine adds 5 months to median OS versus azacitidine alone

Jun 17, 2020

Early Palliation: Boon for AML Patients on Intensive Chemo

Intervention led to marked improvements in QoL, mental distress, end-of-life care

Jun 02, 2020

COVID-19 Mortality Spikes in Patients With Lung, Blood Cancers

Those with metastatic disease also at special risk for poor outcomes

Apr 28, 2020

DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds

Apixaban monotherapy matches dalteparin in non-inferiority trial

Mar 29, 2020

Bringing Transplant to More Patients With AML

Conditioning with radiolabeled antibody leads to successful transplantation in 84% of older patients

Feb 25, 2020

New CAR-T Makes Case for Aggressive Lymphomas

Largest trial to date shows 73% ORR, 53% CR, potential for outpatient treatment

Feb 25, 2020

Stem-Cell Transplant Trial Ends in a Draw

Similar PFS with haploidentical bone marrow, double unrelated umbilical cord blood

Feb 24, 2020

Myeloablative Therapy Prevails in AML Transplant Study

Better survival, fewer relapses compared with reduced-intensity conditioning

Feb 21, 2020

Better Quality CR With One AML Therapy vs Another?

Longer survival after CR/CRi with CPX-351 than with 7+3 in patients with AML-MRC

Feb 21, 2020

Gains in Stem Cell Transplant Mortality Over Last 25 Years

But outcomes still "far from perfect"

Jan 20, 2020

Higher Risk of Shingles Seen in Patients With Certain Cancers

Vaccine development may help with prevention of herpes zoster in this population

Dec 31, 2019

Survival Bump With Oral AML Maintenance

Ten-month OS gain, doubling of RFS with oral azacitidine in transplant-ineligible patients

Dec 10, 2019

IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR

Prognostic tool may predict who is likely to achieve a relatively long remission

Oct 15, 2019

FCR Still an Option in IGHV-Unmutated CLL?

Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit

Oct 08, 2019

Ibrutinib's Cardiotoxicity Comes Into Focus

Study identifies new cardiac events linked to so-called targeted therapy

Sep 25, 2019

Overall Survival Data in for Gilteritinib as AML Salvage Tx

FLT3 Inhibitor tops chemotherapy in randomized trial

Apr 01, 2019

Transplant No Help in Hypodiploid ALL

Similar 5-year outcomes with or without HSCT, regardless of MRD status

Mar 29, 2019

Are Patients Better Off With Image-Guided Bone Marrow Biopsy?

Prospect of sedation has some going to interventional radiology

Mar 29, 2019

Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers

Extended beyond 5 years for most types with greater risk seen in young patients

Dec 20, 2018

Higher Risk of Shingles Seen in Patients With Certain Cancers

Vaccine development may help with prevention of herpes zoster in this population

Dec 14, 2018

ASH Poster Rounds: Obesity Impacts CLL Survival in Women

Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib

Dec 06, 2018

Chemo-Free Tx Tops Best Option in Younger CLL Patients

Improved overall survival and safety with ibrutinib-based therapy

Dec 04, 2018

Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapies

Studies test addition of targeted agents, immunotherapy

Dec 03, 2018

CAR T-Cell Responses Prove Durable in ALL, DLBCL

Two studies demonstrate long-term control in relapsed/refractory disease

Dec 01, 2018

Ibrutinib Alone Wins in Older CLL Patients

Adding rituximab offered no added benefit

Dec 01, 2018

Sneak Peek at Practice-Changing Research From ASH 2018

"Big trials, big results," plus sickle cell disease and CAR T-cell therapies

Nov 30, 2018

Levaquin With Chemo Reduces Bacteremia in Pediatric AML/ALL

But no advantage seen among those undergoing transplant

Sep 11, 2018

FDA Warns Against Long-Term Zmax Use in Certain Cancer Patients

Heightened risk of relapse, death seen in study of stem cell transplant recipients

Aug 03, 2018

Decades Later, Mortality for Childhood Transplant Recipients Remains High

Elevated risk requires closer follow-up care

Jul 27, 2018

Nothing Good for Older Lung Cancer Patients From Add-On Cisplatin

Two trials show no survival benefit and more toxicity

Jul 26, 2018

Second Transplant vs Donor Lymphocyte Infusion in Relapsed AML

Both options viable, benefit more clear in certain groups

Jul 12, 2018

FLT3-ITD Inhibitor Improves Survival in Relapsed AML

More quizartinib-treated patients went on to stem cell transplant

Jun 19, 2018

Lymphoma Risk with JAK Inhibitors for MPNs

Preexisting aberrant B-cell clone implicated

Jun 18, 2018

Ivosidenib Induces Deep Remissions in IDH1-Mutant AML

On strength of phase I data, drug appears headed for FDA approval

Jun 03, 2018

Algorithm Helps Manage Fever

Pediatric cancer patients with non-neutropenic fever could benefit

May 08, 2018

Make the Diagnosis: What鈥檚 to Blame for his Rash and Paresthesia?

Case Findings: A 52-year-old man who was undergoing chemotherapy for leukemia went to the ED 5 days after receiving cytarabine. He complained of a rapid onset of erythematous lesions on his palms and soles accompanied by tingling and burning sensations. Can you diagnose the patient?

Apr 25, 2018

New Clues to CAR T-Cell Failure

Chemo effects, T cell energy sources

Mar 16, 2018

Gladiator Blood and Liquid Gold: Good for What Ails You?

A new book by Lydia Kang, MD, reviews the most dubious cures in history

Dec 19, 2017

Mixed Results with Regimens for Older AML Patients

Positive data with venetoclax, liposomal cytarabine-daunorubicin

Dec 14, 2017